People living with HIV in California were highly satisfied with telephone visits during the height of the COVID-19 pandemic ...

As FDA Filing Approaches for Tab-Cel in EBV+ PTLD, Decades of Science Bear Fruit ...

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community ...

Tiago Biachi, MD, PhD, discusses the challenges of treating gastrointestinal (GI) cancers, particularly the limited effectiveness of immunotherapy for "cold tumors" and the need to make them more ...

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

A panelist discusses how comprehensive care coordination between specialists, proactive adverse effect management, and innovative care models can optimize treatment outcomes for Lambert-Eaton ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

Simple reaction time tasks given to patients living with glaucoma had different response times based on whether the task was visual or auditory, according to a new study published in the European ...

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...